Published in Mech Ageing Dev on January 12, 2010
Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol (2013) 1.32
When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes. Front Immunol (2013) 1.03
Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Ageing (2011) 0.96
NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr) (2011) 0.90
T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance. World J Nephrol (2014) 0.83
Treatment of graft-versus-host disease with naturally occurring T regulatory cells. BioDrugs (2013) 0.82
Flow cytometry and solid organ transplantation: a perfect match. Immunol Invest (2014) 0.76
Immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity. Curr Opin Organ Transplant (2015) 0.75
Telomere Length Assessment for Prediction of Organ Transplantation Outcome. Future or Failure: A Review of the Literature. Med Sci Monit (2017) 0.75
Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation. PLoS One (2016) 0.75
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol (2002) 3.41
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin Immunol (2009) 2.71
Mechanisms of rejection: current perspectives. Transplantation (2012) 2.19
Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell (2010) 2.10
IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med (2005) 2.07
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med (2010) 2.01
Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease. Pol Arch Med Wewn (2013) 2.00
Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A (2007) 1.81
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes (2009) 1.78
Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens (2007) 1.74
IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol (2011) 1.72
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol (2010) 1.72
CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol (2004) 1.60
Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol (2004) 1.59
Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol (2002) 1.59
Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg (2012) 1.45
[Analysis of occurrence of DRB and DQ alleles in sarcoidosis and tuberculosis from Northern Poland]. Pneumonol Alergol Pol (2007) 1.41
Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant (2004) 1.40
Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur J Immunol (2008) 1.36
The impact of memory T cells on rejection and the induction of tolerance. Transplantation (2006) 1.34
CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol (2006) 1.34
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation. Transplantation (2003) 1.31
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol (2006) 1.28
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol (2011) 1.25
Moving to tolerance: clinical application of T regulatory cells. Semin Immunol (2011) 1.25
Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation (2008) 1.22
Regenerative medicine and organ transplantation: past, present, and future. Transplantation (2011) 1.14
Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Transplantation (2006) 1.14
Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav Immun (2004) 1.12
Current diagnostic evaluation of autosomal dominant polycystic kidney disease. Pol Arch Med Wewn (2008) 1.10
The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy. Diabetes Res Clin Pract (2007) 1.10
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. Am J Kidney Dis (2008) 1.09
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells. J Immunol (2008) 1.09
Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol (2010) 1.08
The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant (2010) 1.07
Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells (2008) 1.07
Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif Organs (2010) 1.07
Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol (2006) 1.07
[Modern treatment of autosomal dominant polycystic kidney disease]. Pol Merkur Lekarski (2008) 1.06
Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev (2005) 1.03
Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? Transplantation (2007) 1.03
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A (2013) 1.03
The time is crucial for ex vivo expansion of T regulatory cells for therapy. Cell Transplant (2011) 1.02
Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation (2009) 1.02
Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy. Cytometry A (2009) 1.02
Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation (2011) 1.00
Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. Front Biosci (2007) 1.00
Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Mediators Inflamm (2007) 1.00
Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection. Sci Transl Med (2011) 0.99
In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging. PLoS One (2010) 0.99
From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly. Biogerontology (2008) 0.98
The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes. Mediators Inflamm (2013) 0.96
Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells. Transplantation (2010) 0.96
Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation (2003) 0.95
Costimulation blockade: current perspectives and implications for therapy. Transplantation (2013) 0.95
Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques. J Immunol Methods (2005) 0.95
Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection. Eur J Immunol (2008) 0.95
Adipose tissue-derived stem cells in clinical applications. Expert Opin Biol Ther (2013) 0.94
Transplantation tolerance: lessons from experimental rodent models. Transpl Int (2007) 0.94
Immunogenicity of embryonic stem cell-derived progenitors after transplantation. Curr Opin Organ Transplant (2011) 0.94
A comparison of protocols used to generate insulin-producing cell clusters from mouse embryonic stem cells. Stem Cells (2008) 0.94
Regulatory T cells as modulators of chronic allograft dysfunction. Curr Opin Immunol (2011) 0.93
Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo. Transplantation (2007) 0.93
Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation (2011) 0.93
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model. Transplantation (2013) 0.92
Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol (2008) 0.92
Continuous cognitive improvement 1 year following successful kidney transplant. Kidney Int (2011) 0.92
Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells. Eur J Immunol (2011) 0.92
Induction of transplantation tolerance-the potential of regulatory T cells. Transpl Immunol (2005) 0.92
Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters. Transplantation (2009) 0.91
Translating tolerogenic therapies to the clinic - where do we stand? Front Immunol (2012) 0.91
Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. Hum Immunol (2013) 0.90
Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy. Transplantation (2011) 0.90
Donor reactive regulatory T cells. Curr Opin Organ Transplant (2009) 0.90
Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Acta Biochim Pol (2010) 0.90
Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harb Perspect Med (2013) 0.90
T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol (2010) 0.90
Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. J Immunol (2004) 0.90
Low serum angiogenin concentrations in patients with type 2 diabetes. Diabetes Care (2007) 0.89
Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol (2010) 0.89
Tolerance: one transplant for life. Transplantation (2014) 0.89
[Hypertensive nephropathy: pathogenesis, diagnosis and treatment]. Pol Merkur Lekarski (2003) 0.89
CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Transplantation (2006) 0.89
Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation. Transplantation (2010) 0.89
Regulatory T cells in transplantation. Curr Opin Immunol (2002) 0.89
Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS One (2010) 0.89
Examination of serum miRNA levels in kidney transplant recipients with acute rejection. Transplantation (2014) 0.88
FoxP3, Helios, and SATB1: roles and relationships in regulatory T cells. Int Immunopharmacol (2013) 0.88